Internal Medicine, Hematology & Oncology · New Windsor, NY
NPI
1780798116
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
575 Hudson Valley Ave, Suite100
New Windsor, NY, 12553
Phone (845) 565-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$508K
67,788 services
Medicare patients, 2024
286
Average age 76
Drug cost, 2024
$4.9M
1,716 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Javier Ruiz was code Q5106 (injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units), 5,691 times for 16 patients. In total Javier Ruiz billed 67,788 services in 73 codes, and Medicare paid $508K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 5,691 | 16 | $5.90 | $34K |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 3,490 | 48 | $1.72 | $6,008 |
| 85025 Blood Count | Office | 1,857 | 233 | $7.59 | $14K |
| 36415 Venipuncture Blood Collection | Office | 1,823 | 231 | $8.63 | $16K |
| 80053 Clinical Chemistry | Office | 1,379 | 220 | $10.32 | $14K |
| 99213 Office E&M - Established | Office | 1,314 | 165 | $76.51 | $101K |
| 83735 Clinical Chemistry | Office | 1,082 | 192 | $6.56 | $7,096 |
| 82784 Immunoassay | Office | 857 | 123 | $9.11 | $7,807 |
| 96372 Injection Administration | Office | 773 | 72 | $12.38 | $9,566 |
| 82728 Clinical Chemistry | Office | 733 | 155 | $13.36 | $9,793 |
| 83550 Clinical Chemistry | Office | 730 | 155 | $8.57 | $6,256 |
| 83540 Clinical Chemistry | Office | 729 | 155 | $6.34 | $4,622 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 646 | 55 | $0.51 | $331 |
| 99214 Office E&M - Established | Office | 589 | 184 | $106.29 | $63K |
| 82607 Clinical Chemistry | Office | 498 | 210 | $14.72 | $7,331 |
By year: 2022 $477K for 42,797 services; 2023 $592K for 49,425 services; 2024 $508K for 67,788 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,857 | 233 | $7.59 | $14K |
| 36415 Venipuncture Blood Collection | 1,823 | 231 | $8.63 | $16K |
| 80053 Clinical Chemistry | 1,379 | 220 | $10.32 | $14K |
| 83735 Clinical Chemistry | 1,082 | 192 | $6.56 | $7,096 |
| 82784 Immunoassay | 857 | 123 | $9.11 | $7,807 |
| 82728 Clinical Chemistry | 733 | 155 | $13.36 | $9,793 |
| 83550 Clinical Chemistry | 730 | 155 | $8.57 | $6,256 |
| 83540 Clinical Chemistry | 729 | 155 | $6.34 | $4,622 |
| 82607 Clinical Chemistry | 498 | 210 | $14.72 | $7,331 |
| 82746 Clinical Chemistry | 462 | 201 | $14.32 | $6,614 |
Medicare prescription drug claims, 2024
In 2024, the drug Javier Ruiz prescribed most often to Medicare patients was Warfarin Sodium, with 147 prescriptions and refills. In total Javier Ruiz wrote 1,716 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 147 | 413 | 30 | $1,593 |
| Eliquis Apixaban | 118 | 258 | 31 | $148K |
| Xgeva Denosumab | 76 | 76 | 11 | $246K |
| Zarxio Filgrastim-Sndz | 63 | 63 | 13 | $236K |
| Reblozyl Luspatercept-Aamt | 51 | 51 | Under 11 | $512K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 49 | 49 | Under 11 | $329 |
| Enoxaparin Sodium Generic | 48 | 48 | 12 | $6,086 |
| Granisetron Hcl Generic | 46 | 46 | 12 | $1,101 |
| Granisetron Hcl Granisetron Hcl/Pf | 45 | 45 | 15 | $981 |
| Potassium Chloride Generic | 43 | 43 | Under 11 | $258 |
| Procrit Epoetin Alfa | 38 | 39 | Under 11 | $138K |
| Retacrit Epoetin Alfa-Epbx | 32 | 36 | Under 11 | $55K |
| Lenalidomide Generic | 31 | 31 | Under 11 | $464K |
| Perjeta Pertuzumab | 30 | 30 | Under 11 | $216K |
| Herceptin Trastuzumab | 30 | 30 | Under 11 | $188K |
Brand drugs: - claims; generic drugs: 1,024 claims; opioid claims: 50.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Javier Ruiz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.